India Glycols Financials
| INDIAGLYCO | 765.60 13.10 1.74% |
Operating Margin 0.0841 | PE Ratio 13.4613 | Profit Margin 0.0573 | Payout Ratio 0.1361 | Return On Equity 0.0951 |
India | Select Account or Indicator |
Understanding current and past India Glycols Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of India Glycols' financial statements are interrelated, with each one affecting the others. For example, an increase in India Glycols' assets may result in an increase in income on the income statement.
The data published in India Glycols' official financial statements usually reflect India Glycols' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of India Glycols Limited. For example, before you start analyzing numbers published by India accountants, it's critical to develop an understanding of what India Glycols' liquidity, profitability, and earnings quality are in the context of the Chemicals space in which it operates.
Please note, the presentation of India Glycols' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, India Glycols' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in India Glycols' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of India Glycols Limited. Please utilize our Beneish M Score to check the likelihood of India Glycols' management manipulating its earnings.
India Glycols Stock Summary
India Glycols competes with Steel Authority, Indian Metals, Kingfa Science, Alkali Metals, and Krebs Biochemicals. India Glycols is entity of India. It is traded as Stock on NSE exchange.Specialization | Basic Materials, Materials |
| Instrument | India Stock View All |
| Exchange | National Stock Exchange of India |
| ISIN | INE560A01015 |
| Business Address | Plot No 2-B, |
| Sector | Chemicals |
| Industry | Materials |
| Benchmark | NYSE Composite |
| Website | www.indiaglycols.com |
| Phone | 91 12 0686 0000 |
You should never invest in India Glycols without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of India Stock, because this is throwing your money away. Analyzing the key information contained in India Glycols' financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
India Glycols Key Financial Ratios
Generally speaking, India Glycols' financial ratios allow both analysts and investors to convert raw data from India Glycols' financial statements into concise, actionable information that can be used to evaluate the performance of India Glycols over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that India Glycols Limited reports annually and quarterly.| Revenue | 32.94 B | |||
| Gross Profit | 10.3 B | |||
| EBITDA | 4.02 B |
India Glycols Key Balance Sheet Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Assets | 40.9B | 41.2B | 46.3B | 48.6B | 56.2B | 34.5B | |
| Other Current Liab | 1K | 2.6B | 2.9B | 2.4B | 6.7B | 7.1B | |
| Net Debt | 10.0B | 11.3B | 10.3B | 11.1B | 12.1B | 12.4B | |
| Accounts Payable | 7.7B | 6.3B | 6.8B | 7.5B | 11.0B | 11.5B | |
| Cash | 36.5M | 33.9M | 70.5M | 19.7M | 1.4B | 1.4B | |
| Inventory | 6.8B | 6.1B | 6.9B | 7.5B | 11.1B | 5.9B | |
| Other Current Assets | 1K | 1.7B | 2.0B | 1.7B | 3.2B | 1.8B | |
| Total Liab | 30.5B | 29.5B | 28.6B | 29.6B | 35.7B | 26.0B | |
| Total Current Assets | 15.9B | 17.1B | 16.1B | 16.5B | 19.4B | 13.9B | |
| Intangible Assets | 20.4M | 18.7M | 16.5M | 19M | 16.3M | 30.3M | |
| Net Receivables | 8.7B | 9.0B | 6.7B | 4.4B | 3.8B | 6.8B | |
| Retained Earnings | 8.5B | 9.8B | 16.1B | 17.2B | 19.7B | 20.7B | |
| Short Term Debt | 5.8B | 6.2B | 5.1B | 5.5B | 6.0B | 6.6B | |
| Other Liab | 6.5B | 6.7B | 5.7B | 5.3B | 6.1B | 6.2B | |
| Net Tangible Assets | 10.3B | 11.7B | 17.9B | 19.0B | 21.8B | 22.9B | |
| Other Assets | 1K | 714.6M | 1.3B | 73.9M | 66.5M | 63.2M | |
| Long Term Debt | 4.1B | 5.1B | 5.4B | 5.5B | 7.3B | 4.7B | |
| Short Long Term Debt | 5.7B | 4.8B | 5.0B | 5.4B | 6.0B | 5.5B | |
| Long Term Debt Total | 4.2B | 5.2B | 5.4B | 5.7B | 6.5B | 3.9B | |
| Net Invested Capital | 20.1B | 21.6B | 28.3B | 30.0B | 33.7B | 26.7B |
India Glycols Key Income Statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Interest Expense | 1.3B | 713.7M | 579.9M | 999.6M | 1.2B | 751.4M | |
| Total Revenue | 34.2B | 22.5B | 28.1B | 26.5B | 32.9B | 25.7B | |
| Gross Profit | 10.3B | 7.1B | 8.5B | 10.7B | 6.1B | 9.1B | |
| Operating Income | 2.4B | 2.0B | 1.9B | 2.3B | 3.0B | 1.6B | |
| Ebit | 3.0B | 2.0B | 2.1B | 2.4B | 3.0B | 2.1B | |
| Ebitda | 3.9B | 2.8B | 2.9B | 3.3B | 4.0B | 3.0B | |
| Cost Of Revenue | 23.9B | 15.4B | 19.7B | 15.8B | 26.8B | 16.5B | |
| Income Before Tax | 1.7B | 1.2B | 3.7B | 1.7B | 2.1B | 2.2B | |
| Net Income | 1.1B | 1.3B | 3.4B | 1.3B | 1.7B | 1.8B | |
| Income Tax Expense | 592.5M | 112.8M | 394.3M | 239.6M | 503.2M | 528.4M | |
| Tax Provision | 592.5M | 112.8M | 394.3M | 239.6M | 503.2M | 367.8M | |
| Interest Income | 1.6B | 826.6M | 487.8M | 885.9M | 797.3M | 799.4M | |
| Net Interest Income | (1.4B) | (833.8M) | (696.6M) | (999.6M) | (1.2B) | (1.3B) |
India Glycols Key Cash Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change To Inventory | (351.5M) | (34.2M) | (116.6M) | (636.2M) | (3.5B) | (3.3B) | |
| Change In Cash | (233.2M) | (2.6M) | 36.6M | (50.8M) | 1.3B | 1.4B | |
| Free Cash Flow | 1.9B | (115.5M) | (2.6B) | (1.1B) | (2.0B) | (1.9B) | |
| Depreciation | 829.7M | 801.2M | 802.9M | 939.6M | 1.0B | 873.2M | |
| Other Non Cash Items | 1.1B | 801.5M | (1.9B) | (149.6M) | 2.1B | 2.2B | |
| Dividends Paid | 443.3M | 3.8M | 183.9M | 230.4M | (229.7M) | (218.2M) | |
| Capital Expenditures | 1.5B | 1.5B | 3.8B | 4.4B | 5.5B | 5.8B | |
| Net Income | 1.7B | 1.2B | 3.5B | 1.5B | 1.7B | 1.8B | |
| End Period Cash Flow | 36.5M | 33.9M | 70.5M | 19.7M | 1.4B | 1.4B | |
| Investments | (26.4M) | (1.3B) | 1.5M | (3.3B) | (5.0B) | (4.8B) | |
| Net Borrowings | (313.3M) | 1.4B | (953.3M) | 1.2B | 1.4B | 1.5B | |
| Change To Netincome | 1.1B | 683.0M | (1.8B) | 135.9M | 122.3M | 116.2M |
India Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining India Glycols's current stock value. Our valuation model uses many indicators to compare India Glycols value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across India Glycols competition to find correlations between indicators driving India Glycols's intrinsic value. More Info.India Glycols Limited is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers reporting about 0.39 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for India Glycols Limited is roughly 2.56 . Comparative valuation analysis is a catch-all model that can be used if you cannot value India Glycols by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for India Glycols' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.India Glycols Limited Systematic Risk
India Glycols' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. India Glycols volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty with a total number of output elements of thirty-one. The Beta measures systematic risk based on how returns on India Glycols Limited correlated with the market. If Beta is less than 0 India Glycols generally moves in the opposite direction as compared to the market. If India Glycols Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one India Glycols Limited is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of India Glycols is generally in the same direction as the market. If Beta > 1 India Glycols moves generally in the same direction as, but more than the movement of the benchmark.
India Glycols Limited Total Assets Over Time
About India Glycols Financials
What exactly are India Glycols Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include India Glycols' income statement, its balance sheet, and the statement of cash flows. Potential India Glycols investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although India Glycols investors may use each financial statement separately, they are all related. The changes in India Glycols's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on India Glycols's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.Steps to analyze India Glycols Financials for Investing
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as India Glycols is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of India has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it. In summary, you can determine if India Glycols' financials are consistent with your investment objective using the following steps:- Review India Glycols' balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
- Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
- Study the cash flow inflows and outflows to understand India Glycols' liquidity and solvency.
- Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
- Compare India Glycols' financials to those of its peers to see how it stacks up and identify any potential red flags.
- Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if India Glycols' stock is overvalued or undervalued.
India Glycols June 4, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of India Glycols help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of India Glycols Limited. We use our internally-developed statistical techniques to arrive at the intrinsic value of India Glycols Limited based on widely used predictive technical indicators. In general, we focus on analyzing India Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build India Glycols's daily price indicators and compare them against related drivers.
| Information Ratio | (0.14) | |||
| Maximum Drawdown | 10.94 | |||
| Value At Risk | (2.53) | |||
| Potential Upside | 2.49 |
Other Information on Investing in India Stock
India Glycols financial ratios help investors to determine whether India Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in India with respect to the benefits of owning India Glycols security.